BAMF
PRCT icon

BI Asset Management Fondsmaeglerselskab’s Procept Biorobotics PRCT Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-695
Closed -$40K – 877
2025
Q1 		$40K Buy
+695
New +$47.5K ﹤0.01% 843

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's PRCT Position: Q2 2025 in Review

BI Asset Management Fondsmaeglerselskab sold out of Procept Biorobotics (PRCT) in Q2 2025, closing a stake of 695 shares — an estimated $40K sold.

BI Asset Management Fondsmaeglerselskab first reported a position in PRCT in Q1 2025 and held it in 1 quarter. The position peaked at $40K in Q1 2025. 271 funds tracked by Wall St. Rank hold PRCT as of Q2 2025.

  • BI Asset Management Fondsmaeglerselskab reported no remaining Procept Biorobotics position as of Q2 2025 after selling out during the quarter.
  • BI Asset Management Fondsmaeglerselskab sold 695 Procept Biorobotics shares in Q2 2025, an estimated $40K.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Procept Biorobotics in Q1 2025 and held it in 1 quarter.
  • BI Asset Management Fondsmaeglerselskab's Procept Biorobotics position peaked at $40K in Q1 2025.
  • 271 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2025.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2025, filed 14 Aug 2025.